These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 23813757

  • 1. The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study.
    Orchard TJ, Lyons TJ, Cleary PA, Braffett BH, Maynard J, Cowie C, Gubitosi-Klug RA, Way J, Anderson K, Barnie A, Villavicencio S, DCCT/EDIC Research Group.
    Diabetes Care; 2013 Oct; 36(10):3146-53. PubMed ID: 23813757
    [Abstract] [Full Text] [Related]

  • 2. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
    Fährmann ER, Adkins L, Loader CJ, Han H, Rice KM, Denvir J, Driscoll HK.
    Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
    [Abstract] [Full Text] [Related]

  • 3. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.
    JAMA; 2003 Oct 22; 290(16):2159-67. PubMed ID: 14570951
    [Abstract] [Full Text] [Related]

  • 4. RISK FACTORS FOR HEARING IMPAIRMENT IN TYPE 1 DIABETES.
    Braffett BH, Lorenzi GM, Cowie CC, Gao X, Bainbridge KE, Cruickshanks KJ, Kramer JR, Gubitosi-Klug RA, Larkin ME, Barnie A, Lachin JM, Schade DS, DCCT/EDIC Research Group.
    Endocr Pract; 2019 Dec 22; 25(12):1243-1254. PubMed ID: 31412233
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Cleary PA, Braffett BH, Orchard T, Lyons TJ, Maynard J, Cowie C, Gubitosi-Klug RA, Way J, Anderson K, Barnie A, Villavicencio S, DCCT/EDIC Research Group.
    Diabetes Technol Ther; 2013 Jun 22; 15(6):466-74. PubMed ID: 23882708
    [Abstract] [Full Text] [Related]

  • 9. Understanding Metabolic Memory: A Tale of Two Studies.
    Miller RG, Orchard TJ.
    Diabetes; 2020 Mar 22; 69(3):291-299. PubMed ID: 32079705
    [Abstract] [Full Text] [Related]

  • 10. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
    Diabetes; 1997 Nov 22; 46(11):1829-39. PubMed ID: 9356033
    [Abstract] [Full Text] [Related]

  • 11. Predictors of Change in Skin Intrinsic Fluorescence in Type 1 Diabetes: The Epidemiology of Diabetes Complications Study.
    Tomaszewski EL, Orchard TJ, Hawkins MS, Conway RBN, Buchanich JM, Maynard J, Songer T, Costacou T.
    J Diabetes Sci Technol; 2021 Nov 22; 15(6):1368-1376. PubMed ID: 33993770
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes.
    Kilpatrick ES, Rigby AS, Atkin SL.
    Diabetes Care; 2009 Oct 22; 32(10):1901-3. PubMed ID: 19549736
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Diabetes Care; 1999 Jan 22; 22(1):99-111. PubMed ID: 10333910
    [Abstract] [Full Text] [Related]

  • 18. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM, DCCT/EDIC Research Group.
    Diabetes; 2006 Dec 22; 55(12):3556-65. PubMed ID: 17130504
    [Abstract] [Full Text] [Related]

  • 19. Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study.
    Hainsworth DP, Bebu I, Aiello LP, Sivitz W, Gubitosi-Klug R, Malone J, White NH, Danis R, Wallia A, Gao X, Barkmeier AJ, Das A, Patel S, Gardner TW, Lachin JM, Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Diabetes Care; 2019 May 22; 42(5):875-882. PubMed ID: 30833368
    [Abstract] [Full Text] [Related]

  • 20. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct 22; 45(10):1289-98. PubMed ID: 8826962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.